mayo clinic diet glp 1 Healthy weight loss when GLP-1s are not an option The Mayo Clinic Diet: Weight-Loss
Description
The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.
PlexusDx explains potential interactions, absorption concerns, and how to safely use both medications together
As low-price gyms race to expand, Crunch is investing in community and AI-powered technology to keep members engaged for the long haul.
Understanding what triggers these symptoms helps you decide whether to adjust technique or contact your provider
In 2025, our product investments meaningfully increased engagement, and engagement translates into better results at every stage of the journey.
The Unmet Challenge of Medication Nonadherence
